Table.

Patient characteristics of the study group.

ARDS, acute respiratory distress syndrome; BMI, body mass index; CMV, cytomegalovirus; COPD, chronic obstructive pulmonary disease; CRA, cardiorespiratory arrest; D-anti-Xa, reagent with dextran sulfate; ECMO, extracorporeal membrane oxygenation; ENT, ear, nose, and throat; IS, immunosuppression; NA, not available; NC, non-collected; ND-anti-Xa, reagent without dextran sulfate; STEMI, ST-elevation myocardial infarction; SOFA, sequential organ failure assessment; VA, venoarterial; VV, venovenous.

^aAnti-Xa level: the day the bleeding or thrombotic event occurred.